MyMD Pharmaceuticals, Inc.
NASDAQ:MYMD
1.82 (USD) • At close July 23, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | MyMD Pharmaceuticals, Inc. |
Symbool | MYMD |
Munteenheid | USD |
Prijs | 1.81 |
Beurswaarde | 4,290,460 |
Dividendpercentage | 0% |
52-weken bereik | 1.75 - 63.9 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Christopher C. Chapman Jr., M.D. |
Website | https://www.mymd.com |
An error occurred while fetching data.
Over MyMD Pharmaceuticals, Inc.
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)